Triple-negative breast cancer (TNBC) is defined by the lack of expression of the estrogen receptor (ER), the progesterone receptor (PR) and the absence of human epidermal growth factor receptor 2 (HER2) overexpression and/or gene amplification. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.